他汀类药物作为强效抗炎药。 - Suppr

Suppr

超能文献

Statins as potent antiinflammatory drugs.

作者信息

Lefer David J

出版信息

Circulation. 2002 Oct 15;106(16):2041-2. doi: 10.1161/01.cir.0000033635.42612.88.

DOI:10.1161/01.cir.0000033635.42612.88

PMID:12379569

Abstract

摘要

相似文献

Statins as potent antiinflammatory drugs.他汀类药物作为强效抗炎药。

Circulation. 2002 Oct 15;106(16):2041-2. doi: 10.1161/01.cir.0000033635.42612.88.

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin.辛伐他汀抑制金黄色葡萄球菌α毒素的炎症特性。

Circulation. 2002 Oct 15;106(16):2104-10. doi: 10.1161/01.cir.0000034048.38910.91.

Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.HMG-CoA还原酶抑制剂在糖尿病微血管病变中的调节作用。

FASEB J. 2004 May;18(7):805-15. doi: 10.1096/fj.03-0839rev.

HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury.

FASEB J. 2001 Jun;15(8):1454-6. doi: 10.1096/fj.00-0819fje.

The cardioprotective effects of statins.他汀类药物的心脏保护作用。

Coron Artery Dis. 2004 Aug;15(5):243-5. doi: 10.1097/01.mca.0000130228.11062.4d.

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.HMG-CoA还原酶抑制剂辛伐他汀可显著提高脓毒症小鼠模型的存活率。

Circulation. 2004 Jun 1;109(21):2560-5. doi: 10.1161/01.CIR.0000129774.09737.5B. Epub 2004 May 3.

Beneficial cardiovascular pleiotropic effects of statins.他汀类药物有益的心血管多效性作用。

Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43. doi: 10.1161/01.CIR.0000131517.20177.5a.

Perspectives on the cardioprotective effects of statins.他汀类药物心脏保护作用的观点。

Curr Med Chem. 2003 Aug;10(16):1593-601. doi: 10.2174/0929867033457205.

PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.PPARα 介导辛伐他汀在酵母聚糖诱导的多器官衰竭实验模型中的抗炎作用。

Br J Pharmacol. 2011 Jun;163(3):609-23. doi: 10.1111/j.1476-5381.2011.01248.x.

HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.HMG-CoA还原酶抑制剂可抑制内皮细胞胞吐作用并减小心肌梗死面积。

Circ Res. 2005 Jun 10;96(11):1185-92. doi: 10.1161/01.RES.0000170229.49776.81. Epub 2005 May 19.

引用本文的文献

Longitudinal association between statins and changes in CT-derived body composition in patients with abdominal aortic aneurysm.他汀类药物与腹主动脉瘤患者CT衍生身体成分变化之间的纵向关联。

J Cachexia Sarcopenia Muscle. 2025 Apr;16(2). doi: 10.1002/jcsm.13565.

Efficacy of Simvastatin in Inhibiting Bone Resorption and Promoting Healing in Delayed Tooth Avulsion: A Case Series.辛伐他汀对延迟性牙脱位抑制骨吸收及促进愈合的疗效：病例系列研究

Cureus. 2025 Feb 17;17(2):e79139. doi: 10.7759/cureus.79139. eCollection 2025 Feb.

Risk stratification analysis of recurrent myocardial infarction in Indian population using inflammatory, lipid, thrombotic and extracellular matrix remodeling markers.使用炎症、脂质、血栓形成和细胞外基质重塑标志物对印度人群复发性心肌梗死进行风险分层分析。

Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202425. doi: 10.21542/gcsp.2024.25.

The Effect of Different Statin-Based Lipid-Lowering Strategies on C-Reactive Protein Levels in Patients With Stable Coronary Artery Disease.不同他汀类药物降脂策略对稳定性冠心病患者 C 反应蛋白水平的影响。

Clin Cardiol. 2024 Jun;47(6):e24301. doi: 10.1002/clc.24301.

Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.在一个大型的、真实世界的肝硬化患者队列中，他汀类药物、二甲双胍和肾素-血管紧张素系统（RAS）抑制剂并未降低静脉曲张出血风险和死亡率。

PLoS One. 2024 Jun 13;19(6):e0302811. doi: 10.1371/journal.pone.0302811. eCollection 2024.

A Retrospective Cohort Study Assessing the Impact of Statin Therapy on Hospital Length of Stay and Inpatient Mortality in COVID-19 Patients.一项评估他汀类药物治疗对COVID-19患者住院时间和住院死亡率影响的回顾性队列研究。

HCA Healthc J Med. 2023 Oct 30;4(5):369-375. doi: 10.36518/2689-0216.1546. eCollection 2023.

Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease.糖尿病与外周动脉疾病中的血栓炎症相关。

Cardiovasc Diabetol. 2023 Sep 21;22(1):257. doi: 10.1186/s12933-023-01990-6.

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review.急性心肌梗死与认知障碍和痴呆风险：综述

Biology (Basel). 2023 Aug 21;12(8):1154. doi: 10.3390/biology12081154.

Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update.急性冠状动脉综合征后血脂异常管理策略的适宜性：2023年更新

Metabolites. 2023 Aug 4;13(8):916. doi: 10.3390/metabo13080916.

The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.两项 II 期临床试验的基本原理和研究设计，旨在研究可溶性鸟苷酸环化酶激活剂 BI 685,509 对代偿性肝硬化患者临床显著门静脉高压的影响。

Trials. 2023 Apr 24;24(1):293. doi: 10.1186/s13063-023-07291-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验